相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characteristics of SARS-CoV-2 and COVID-19
Ben Hu et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy
Parinaz Fozouni et al.
CELL (2021)
Lipid nanoparticles loaded with ribonucleoprotein-oligonucleotide complexes synthesized using a microfluidic device exhibit robust genome editing and hepatitis B virus inhibition
Yuichi Suzuki et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents
Emmeline L. Blanchard et al.
NATURE BIOTECHNOLOGY (2021)
CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice
Daniel Stone et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
CRISPR-Cas13a mediated targeting of hepatitis C virus internal-ribosomal entry site (IRES) as an effective antiviral strategy
Muhammad Usman Ashraf et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates
Kiran Musunuru et al.
NATURE (2021)
Programmable RNA editing with compact CRISPR-Cas13 systems from uncultivated microbes
Chunlong Xu et al.
NATURE METHODS (2021)
Potent programmable antiviral against dengue virus in primary human cells by Cas13b RNP with short spacer and delivery by VLP
Ekapot Singsuksawat et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
Spillover or endemic? Reconsidering the origins of Ebola virus disease outbreaks by revisiting local accounts in light of new evidence from Guinea
James Fairhead et al.
BMJ GLOBAL HEALTH (2021)
Programmable RNA targeting with the single-protein CRISPR effector Cas7-11
Ahsen Ozcan et al.
NATURE (2021)
Inhibition of Hepatitis B Virus by AAV8-Derived CRISPR/SaCas9 Expressed From Liver-Specific Promoters
Kun Yan et al.
FRONTIERS IN MICROBIOLOGY (2021)
In Vitro Inhibition of Influenza Virus Using CRISPR/Cas13a in Chicken Cells
Arjun Challagulla et al.
METHODS AND PROTOCOLS (2021)
Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein
Lin Wang et al.
THERANOSTICS (2021)
Visual detection of porcine reproductive and respiratory syndrome virus using CRISPR-Cas13a
Yafei Chang et al.
TRANSBOUNDARY AND EMERGING DISEASES (2020)
Immunogenicity of Cas9 Protein
Aditi Mehta et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
Timothy R. Abbott et al.
CELL (2020)
CRISPR-Cas13a Cleavage of Dengue Virus NS3 Gene Efficiently Inhibits Viral Replication
Hao Li et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Extinction of all infectious HIV in cell culture by the CRISPR-Cas12a system with only a single crRNA
Zongliang Gao et al.
NUCLEIC ACIDS RESEARCH (2020)
Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing
Yu-Chan Yang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
CRISPR/Cas12a Mediated Genome Editing EnhancesBombyx moriResistance to BmNPV
Zhanqi Dong et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Cas13b-dependent and Cas13b-independent RNA knockdown of viral sequences in mosquito cells following guide RNA expression
Priscilla Ying Lei Tng et al.
COMMUNICATIONS BIOLOGY (2020)
CRISPR/Cas9 ablating viral microRNA promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus
Zhipin Liang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Abrogation of PRRSV infectivity by CRISPR-Cas13b-mediated viral RNA cleavage in mammalian cells
Jin Cui et al.
SCIENTIFIC REPORTS (2020)
CRISPR-Cas13a Inhibits HIV-1 Infection
Lijuan Yin et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
CRISPR based editing of SIV proviral DNA in ART treated non-human primates
Pietro Mancuso et al.
NATURE COMMUNICATIONS (2020)
Insights into Hepatitis B Virus DNA Integration-55 Years after Virus Discovery
Kaitao Zhao et al.
INNOVATION (2020)
CRISPR/Cas9-mediated disruption of the immediate early-0 and 2 as a therapeutic approach to Bombyx mori nucleopolyhedrovirus in transgenic silkworm
Z. Dong et al.
INSECT MOLECULAR BIOLOGY (2019)
Identification of preexisting adaptive immunity to Cas9 proteins in humans
Carsten T. Charlesworth et al.
NATURE MEDICINE (2019)
Small Molecular Inhibitors of DNA Double Strand Break Repair Pathways Increase the ANTI-HBV Activity of CRISPR/Cas9
A. P. Kostyusheva et al.
MOLECULAR BIOLOGY (2019)
Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice
Prasanta K. Dash et al.
NATURE COMMUNICATIONS (2019)
Construction of a One-Vector Multiplex CRISPR/Cas9 Editing System to Inhibit Nucleopolyhedrovirus Replication in Silkworms
Zhanqi Dong et al.
VIROLOGICA SINICA (2019)
Highly Efficient Generation of Pigs Harboring a Partial Deletion of the CD163 SRCR5 Domain, Which Are Fully Resistant to Porcine Reproductive and Respiratory Syndrome Virus 2 Infection
Chunhe Guo et al.
FRONTIERS IN IMMUNOLOGY (2019)
Programmable Inhibition and Detection of RNA Viruses Using Cas13
Catherine A. Freije et al.
MOLECULAR CELL (2019)
Orthologous CRISPR/Cas9 systems for specific and efficient degradation of covalently closed circular DNA of hepatitis B virus
Dmitry Kostyushev et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Deletion of CD163 Exon 7 Confers Resistance to Highly Pathogenic Porcine Reproductive and Respiratory Viruses on Pigs
Haitao Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Generation of Pigs Resistant to Highly Pathogenic-Porcine Reproductive and Respiratory Syndrome Virus through Gene Editing of CD163
Jingyao Chen et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Inhibition of hepatitis B virus replication via HBV DNA cleavage by Cas9 from Staphylococcus aureus
Yu Liu et al.
ANTIVIRAL RESEARCH (2018)
CD163 knockout pigs are fully resistant to highly pathogenic porcine reproductive and respiratory syndrome virus
Huaqiang Yang et al.
ANTIVIRAL RESEARCH (2018)
Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors
Silvana Konermann et al.
CELL (2018)
Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing
Romain Rouet et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Pigs Lacking the Scavenger Receptor Cysteine-Rich Domain 5 of CD163 Are Resistant to Porcine Reproductive and Respiratory Syndrome Virus 1 Infection
Christine Burkard et al.
JOURNAL OF VIROLOGY (2018)
Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein
Winston X. Yan et al.
MOLECULAR CELL (2018)
Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements
Michael Kosicki et al.
NATURE BIOTECHNOLOGY (2018)
Field-deployable viral diagnostics using CRISPR-Cas13
Cameron Myhrvold et al.
SCIENCE (2018)
Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6
Jonathan S. Gootenberg et al.
SCIENCE (2018)
CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
Shuliang Chen et al.
VIRUSES-BASEL (2018)
Excision of Nucleopolyhedrovirus Form Transgenic Silkworm Using the CRISPR/Cas9 System
Zhanqi Dong et al.
FRONTIERS IN MICROBIOLOGY (2018)
One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors
Maren Schiwon et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice
Ramona Bella et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Establishment of a baculovirus-inducible CRISPR/Cas9 system for antiviral research in transgenic silkworms
Zhanqi Dong et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2018)
RNA Interference as a Prospective Tool for the Control of Human Viral Infections
Alesia Levanova et al.
FRONTIERS IN MICROBIOLOGY (2018)
Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9
Hao Li et al.
FRONTIERS IN IMMUNOLOGY (2018)
Base editing: precision chemistry on the genome and transcriptome of living cells
Holly A. Rees et al.
NATURE REVIEWS GENETICS (2018)
Transgenic Clustered Regularly Interspaced Short Palindromic Repeat/Cas9-Mediated Viral Gene Targeting for Antiviral Therapy of Bombyx mori Nucleopolyhedrovirus
Shuqing Chen et al.
JOURNAL OF VIROLOGY (2017)
RNA targeting with CRISPR-Cas13
Omar O. Abudayyeh et al.
NATURE (2017)
Precision engineering for PRRSV resistance in pigs: Macrophages from genome edited pigs lacking CD163 SRCR5 domain are fully resistant to both PRRSV genotypes while maintaining biological function
Christine Burkard et al.
PLOS PATHOGENS (2017)
Diversity, classification and evolution of CRISPR-Cas systems
Eugene V. Koonin et al.
CURRENT OPINION IN MICROBIOLOGY (2017)
Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study
R. Kaminski et al.
GENE THERAPY (2016)
International AIDS Society global scientific strategy: towards an HIV cure 2016
Steven G. Deeks et al.
NATURE MEDICINE (2016)
Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing
Rafal Kaminski et al.
SCIENTIFIC REPORTS (2016)
Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment
Edward M. Kennedy et al.
VIROLOGY (2015)
RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection
Wenhui Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The new frontier of genome engineering with CRISPR-Cas9
Jennifer A. Doudna et al.
SCIENCE (2014)
Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
Hirotaka Ebina et al.
SCIENTIFIC REPORTS (2013)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
CRISPR/Cas, the Immune System of Bacteria and Archaea
Philippe Horvath et al.
SCIENCE (2010)
Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in rhesus macaque
BJ Li et al.
NATURE MEDICINE (2005)
分享论文
